| Characteristics . | Diabetes (n = 646) . | No diabetes (n = 1639) . | ||||||
|---|---|---|---|---|---|---|---|---|
| . | Personalized group (n = 311) . | Standard group (n = 335) . | t or X2 . | P . | Personalized group (n = 835) . | Standard group (n = 804) . | t or X2 . | P . |
| MAR ≥ 55%, (n, %) | 201 (64.6) | – | – | – | 519 (62.2) | – | – | – |
| IIb/IIIa inhibitors, (n, %) | 9 (2.9) | 14 (4.2) | 0.376 | 0.778 | 24 (2.9) | 38 (4.7) | 3.578 | 0.059 |
| Characteristics . | Diabetes (n = 646) . | No diabetes (n = 1639) . | ||||||
|---|---|---|---|---|---|---|---|---|
| . | Personalized group (n = 311) . | Standard group (n = 335) . | t or X2 . | P . | Personalized group (n = 835) . | Standard group (n = 804) . | t or X2 . | P . |
| MAR ≥ 55%, (n, %) | 201 (64.6) | – | – | – | 519 (62.2) | – | – | – |
| IIb/IIIa inhibitors, (n, %) | 9 (2.9) | 14 (4.2) | 0.376 | 0.778 | 24 (2.9) | 38 (4.7) | 3.578 | 0.059 |
Abbreviation: MAR, platelet aggregation rate.
| Characteristics . | Diabetes (n = 646) . | No diabetes (n = 1639) . | ||||||
|---|---|---|---|---|---|---|---|---|
| . | Personalized group (n = 311) . | Standard group (n = 335) . | t or X2 . | P . | Personalized group (n = 835) . | Standard group (n = 804) . | t or X2 . | P . |
| MAR ≥ 55%, (n, %) | 201 (64.6) | – | – | – | 519 (62.2) | – | – | – |
| IIb/IIIa inhibitors, (n, %) | 9 (2.9) | 14 (4.2) | 0.376 | 0.778 | 24 (2.9) | 38 (4.7) | 3.578 | 0.059 |
| Characteristics . | Diabetes (n = 646) . | No diabetes (n = 1639) . | ||||||
|---|---|---|---|---|---|---|---|---|
| . | Personalized group (n = 311) . | Standard group (n = 335) . | t or X2 . | P . | Personalized group (n = 835) . | Standard group (n = 804) . | t or X2 . | P . |
| MAR ≥ 55%, (n, %) | 201 (64.6) | – | – | – | 519 (62.2) | – | – | – |
| IIb/IIIa inhibitors, (n, %) | 9 (2.9) | 14 (4.2) | 0.376 | 0.778 | 24 (2.9) | 38 (4.7) | 3.578 | 0.059 |
Abbreviation: MAR, platelet aggregation rate.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
